A suspected case of an alveolar haemorrhage caused by dasatinib

4Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

A 39-year-old man treated with dasatinib for chronic myelogenous leukaemia presented to our hospital with haemoptysis, coughing, and dyspnoea. Chest radiography and computed tomography revealed groundglass opacities and a crazy-paving pattern. Bronchoalveolar lavage was not performed due to serious hypoxemia and bleeding. Significant bleeding from the peripheral bronchi led to a diagnosis of an alveolar haemorrhage. Dasatinib-induced alveolar haemorrhaging was suspected based on the clinical findings. His condition improved immediately after dasatinib withdrawal and initiation of steroid therapy. Reports of alveolar haemorrhaging induced by dasatinib are rare. As such, this is considered an important case.

Cite

CITATION STYLE

APA

Sakoda, Y., Arimori, Y., Ueno, M., & Matsumoto, T. (2017). A suspected case of an alveolar haemorrhage caused by dasatinib. Internal Medicine, 56(2), 203–206. https://doi.org/10.2169/internalmedicine.56.7363

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free